Related Experiment Video

Updated: Jan 4, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

4.7K

Application of Genome-Wide Association Studies in Coronary Artery Disease

Huilei Zheng1,2,3, Zhiyu Zeng2,3,4, Hong Wen2,3,5

  • 1Department of Medical Examination & Health Management, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Current Pharmaceutical Design
|November 7, 2019
PubMed

Insights

Genome-wide association studies (GWAS) have identified numerous genetic factors contributing to coronary artery disease (CAD). This research summarizes recent GWAS progress, challenges, and future directions for CAD genetic mechanisms.

Area of Science:

  • Genetics
  • Cardiovascular Disease Research
  • Genomics

Background:

  • Coronary artery disease (CAD) is a major global health concern, resulting from a complex interplay of environmental and genetic factors.
  • Understanding the genetic underpinnings of CAD is crucial for developing effective prevention and treatment strategies.
  • Recent advancements in genome-wide association studies (GWAS) have significantly accelerated the discovery of CAD-related genetic factors.

Purpose of the Study:

  • To summarize the key advancements in genome-wide association studies (GWAS) for coronary artery disease (CAD) globally.
  • To analyze the current challenges and future trends in GWAS for CAD research.
  • To guide the translation of genetic research findings into clinical practice for CAD.

Main Methods:

  • Review of recent global genome-wide association studies (GWAS) focused on coronary artery disease (CAD).
  • Analysis of identified genetic susceptibility genes and loci associated with CAD.
  • Discussion of methodological challenges and future research directions in the field.

Main Results:

  • Numerous genetic susceptibility genes and loci for coronary artery disease (CAD) have been successfully identified through GWAS.
  • GWAS has entered a new phase of CAD research, revealing significant genetic contributions.
  • Progress highlights the potential for genetic discoveries to impact clinical understanding and management of CAD.

Conclusions:

  • Genome-wide association studies (GWAS) have made substantial progress in uncovering the genetic architecture of coronary artery disease (CAD).
  • Addressing current challenges in GWAS is essential for advancing CAD genetic research.
  • Future research should focus on translating genetic findings into clinical applications for improved CAD patient outcomes.

Keywords:
Genome-wide association studycoronary artery diseasegenetic factorsgenetic mechanismgenetic susceptibility locussingle nucleotide polymorphism.

More Related Videos

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.3K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.9K

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
829
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
325
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
346
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
554
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
179